Balloon Catheter

C.R. Bard Inc. announced the publication of results from the LEVANT 2 study in the June 24, 2015, online issue of The New England Journal of Medicine. Results from LEVANT 2 demonstrated superior primary patency for the Lutonix 035 drug co...

Medtronic plc announced U.S. Food and Drug Administration (FDA) 510(k) clearance and U.S. launch of the Euphora Semicompliant Balloon Dilatation Catheter. Euphora is a pre-dilatation therapy used during a stent implantation to reopen a narrowed co...

bard, DEB, drug eluting balloon

The first clinical trial in the United States to study the use of drug-coated ...

C.R. Bard, LEVANT 2 results, Lutonix 035 DCB, drug coated balloon, PTA
C.R. Bard Inc. announced the publication of results from the LEVANT 2 study in the June 24, 2015, online issue of The New England Journal of Medicine. Results...
Lutonix DCB, CMS, reimbursement, pass-through payment, outpatient use
C.R. Bard Inc. announced that the U.S. Centers for Medicare and Medicaid Services (CMS) has improved the pass-through payment for the Lutonix drug-coated...
Medtronic, Euphora SC balloon, CE Mark, Europe, Richard Edwards
Medtronic announced the launch of the Euphora semicompliant balloon dilatation catheter in countries that recognize the CE (Conformité Européene) mark in...
Shockwave Medical, Lithoplasty, $40 million, funding, Sofinnova, Venrock
Shockwave Medical announced $40 million in funding, co-led by returning investor Sofinnova Partners and new investor Venrock. Also participating were RA...
Medtronic, Euphora, SC, semicompliant balloon dilatation catheter, FDA, U.S.
The Euphora Semicompliant Balloon Dilatation Catheter is a pre-dilatation therapy used during a stent implantation to reopen a narrowed
Medtronic’s In.Pact Admiral drug-coated balloon (DCB) is for the interventional treatment of peripheral artery disease (PAD) for the...

Articles

C.R. Bard, LEVANT 2 results, Lutonix 035 DCB, drug coated balloon, PTA
C.R. Bard Inc. announced the publication of results from the LEVANT 2 study in the June 24, 2015, online issue of The New England Journal of Medicine. Results...
Shockwave Medical, Lithoplasty, $40 million, funding, Sofinnova, Venrock
Shockwave Medical announced $40 million in funding, co-led by returning investor Sofinnova Partners and new investor Venrock. Also participating were RA...
Cardinal Health announced plans to acquire Johnson & Johnson’s Cordis business, a leading global manufacturer of cardiology and endovascular devices, for $...
Medtronic, In.Pact Admiral DEB, drug coated balloon, drug eluting balloon
Drug-eluting balloons (DEBs) have been one of the long-awaited new transcatheter technologies to help reduce high restenosis rates in peripheral artery disease...

Video Center

Here are a few observations on cardiovascular ultrasound advances I made while attending the 2015...
4 weeks 3 days ago
The latest advances in cardiovascular echocardiography will be presented at the 2015 American...
6 weeks 5 days ago
There were several technology takeaway messages for the future of electrophysiology (EP) at the...
9 weeks 6 days ago
Centricity, webinar, ZFV, ZFP, viewer, remote viewing system, enterprise
Healthcare organizations are demanding more capabilities for image viewers accessed by clinicians. Zero footprint (ZFP) viewers provide imaging tools from...
The webinar "State of the Art in MRI Pediatric Brain Perfusion Imaging" educates participants about the state of the art clinical and emerging translational...
This webinar discusses why contemporary adult cardiac interventions require significant ionizing radiation with potential health risks to both the patient and...